EPS15-NTRK1: a novel NTRK1 oncogenic fusion in patient with lung adenocarcinoma

J Cancer Res Clin Oncol. 2020 Dec;146(12):3389-3392. doi: 10.1007/s00432-020-03416-2. Epub 2020 Oct 9.

Authors

Shengzhuang Yang¹, Lijian Li², Dongsheng Chen², Mingzhe Xiao², Lei Xian³

Affiliations

¹ The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530000, China.
² The State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, 210002, China.
³ The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530000, China. xianleigxykdx@163.com.

PMID: 33037466
DOI: 10.1007/s00432-020-03416-2

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adaptor Proteins, Signal Transducing / genetics*
Adenocarcinoma of Lung / diagnosis*
Adenocarcinoma of Lung / genetics*
Genetic Association Studies
Genetic Predisposition to Disease
Genetic Testing
Humans
Image-Guided Biopsy
Immunohistochemistry / methods
In Situ Hybridization, Fluorescence
Male
Middle Aged
Neoplasm Staging
Oncogene Proteins, Fusion*
Receptor, trkA / genetics*
Tomography, X-Ray Computed

Substances

Adaptor Proteins, Signal Transducing
EPS15 protein, human
NTRK1 protein, human
Oncogene Proteins, Fusion
Receptor, trkA